DJ Abbott Laboratories Stock Outperforms Competitors Despite Losses On The Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ shed 1.19% to $134.01 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.94% to 6,033.11 and the Dow Jones Industrial Average rising 0.75% to 42,515.09.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 5.11% short of its 52-week high of $141.23, which the company reached on March 4th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.20% to $155.22, Pfizer Inc. $(PFE)$ fell 0.57% to $24.40, and Merck & Co. Inc. $(MRK)$ rose 0.07% to $80.96.
Trading volume (5.1 M) remained 1.7 million below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 16, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 16, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.